BUGD.F Stock Overview
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 6/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Bumrungrad Hospital Public Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ฿6.44 |
52 Week High | ฿7.06 |
52 Week Low | ฿6.12 |
Beta | 0.21 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | 17.30% |
Change since IPO | 460.00% |
Recent News & Updates
Recent updates
Shareholder Returns
BUGD.F | US Healthcare | US Market | |
---|---|---|---|
7D | n/a | 2.4% | -3.7% |
1Y | n/a | 0.8% | 20.5% |
Return vs Industry: Insufficient data to determine how BUGD.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how BUGD.F performed against the US Market.
Price Volatility
BUGD.F volatility | |
---|---|
BUGD.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BUGD.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BUGD.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1975 | n/a | Artirat Charukitpipat | www.bumrungrad.com |
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics.
Bumrungrad Hospital Public Company Limited Fundamentals Summary
BUGD.F fundamental statistics | |
---|---|
Market cap | US$4.86b |
Earnings (TTM) | US$190.48m |
Revenue (TTM) | US$694.53m |
25.5x
P/E Ratio7.0x
P/S RatioIs BUGD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BUGD.F income statement (TTM) | |
---|---|
Revenue | ฿25.55b |
Cost of Revenue | ฿12.89b |
Gross Profit | ฿12.65b |
Other Expenses | ฿5.65b |
Earnings | ฿7.01b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | 8.81 |
Gross Margin | 49.52% |
Net Profit Margin | 27.43% |
Debt/Equity Ratio | 0.1% |
How did BUGD.F perform over the long term?
See historical performance and comparison